Clinical outcomes of a prospective randomized comparison of bioreactance monitoring versus pulse‐contour analysis in a stroke‐volume based goal‐directed fluid resuscitation protocol in brain‐dead organ donors
Clinical Transplantation · 2023
DOI: 10.1111/ctr.15110 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Gary F Marklin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mid-America Transplant, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Goals, Tissue and Organ Procurement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Reanimation, Schlaganfall
Abstract (Originalsprache)
Eighty percent of brain‐dead (BD) organ donors develop hypotension and are frequently hypovolemic. Fluid resuscitation in a BD donor is controversial. We have previously published our 4‐h goal‐directed stroke volume (SV)‐based fluid resuscitation protocol which significantly decreased time on vasopressors and increased transplanting four or more organs. The SV was measured by pulse‐contour analysis (PCA) or an esophageal doppler monitor, both of which are invasive. Thoracic bioreactance (BR) is a non‐invasive portable technology that measures SV but has not been studied in BD donors. We performed a randomized prospective comparative study of BR versus PCA technology in our fluid resuscitation protocol in BD donors. Eighty‐four donors (53.1%) were randomized to BR and 74 donors to PCA (46.8%). The two groups were well matched based on 24 demographic, social, and initial laboratory factors, without any significant differences between them. There was no difference in the intravenous fluid infused over the 4‐h study period [BR 2271 ± 823 vs. PCA 2230 ± 962 mL; p = .77]. There was no difference in the time to wean off vasopressors [BR 108.8 ± 61.8 vs. PCA 150.0 ± 68 min p = .07], nor in the number of donors off vasopressors at the end of the protocol [BR 16 (28.6%) vs. PCA 15 (29.4%); p = .92]. There was no difference in the total number of organs transplanted per donor [BR 3.25 ± 1.77 vs. PCA 3.22 ± 1.75; p = .90], nor in any individual organ transplanted. BR was equivalent to PCA in clinical outcomes and provides a simple, non‐invasive, portable technology to monitor fluid resuscitation in organ donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mid-America Transplant, St Louis, Missouri, USA.
- Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
- Viven Health, St Louis, Missouri, USA.
ORCID-Profile: Gary F Marklin
Zitieren
APA
Marklin, G. F., Stephens, M., Gansner, E., Ewald, G., Klinkenberg, W. D., & Ahrens, T. (2023). Clinical outcomes of a prospective randomized comparison of bioreactance monitoring versus pulse‐contour analysis in a stroke‐volume based goal‐directed fluid resuscitation protocol in brain‐dead organ donors. Clinical Transplantation. https://doi.org/10.1111/ctr.15110
Vancouver
Marklin GF, Stephens M, Gansner E, Ewald G, Klinkenberg WD, Ahrens T. Clinical outcomes of a prospective randomized comparison of bioreactance monitoring versus pulse‐contour analysis in a stroke‐volume based goal‐directed fluid resuscitation protocol in brain‐dead organ donors. Clinical Transplantation. 2023. doi:10.1111/ctr.15110
BibTeX
@article{Marklin2023,
author = {Marklin, Gary F and Stephens, Melissa and Gansner, Elyssa and Ewald, Gregory and Klinkenberg, William Dean and Ahrens, Thomas},
title = {Clinical outcomes of a prospective randomized comparison of bioreactance monitoring versus pulse‐contour analysis in a stroke‐volume based goal‐directed fluid resuscitation protocol in brain‐dead organ donors},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.15110}
}
EUVIMED